EWGSOP2 Versus EWGSOP1: Impact on the Prevalence of Sarcopenia and Its Major Health Consequences

被引：55
|
作者：
Locquet, Medea [1 ]
Beaudart, Charlotte [1 ]
Petermans, Jean [2 ]
Reginster, Jean-Yves [1 ]
Bruyere, Olivier [1 ]
机构：
[1] Univ Liege, WHO, Collaborating Ctr Publ Hlth Aspects Musculoskelet, Dept Publ Hlth Epidemiol & Hlth Econ, Liege, Belgium
[2] CHU Liege, Geriatr Dept, Liege, Belgium
来源：
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION | 2019年 / 20卷 / 03期
关键词：
D O I：
10.1016/j.jamda.2018.11.027
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：384 / 385
页数：2
相关论文
共 50 条
  • [41] A translational approach for the clinical application of recently updated definitions of malnutrition (GLIM) and sarcopenia (EWGSOP2)
    Sanchez-Rodriguez, Dolores
    Annweiler, Cedric
    Cederholm, Tommy
    MATURITAS, 2019, 122 : 89 - 90
  • [42] Comparison of revised EWGSOP2 criteria of sarcopenia in patients with cancer using different parameters of muscle mass
    Trussardi Fayh, Ana Paula
    de Sousa, Iasmin Matias
    PLOS ONE, 2021, 16 (09):
  • [43] Using the Updated EWGSOP2 Definition in Diagnosing Sarcopenia in Spanish Older Adults: Clinical Approach
    Arnal-Gomez, Anna
    Iranzo, Maria A. Cebria i
    Tomas, Jose M.
    Tortosa-Chulia, Maria A.
    Balasch-Bernat, Merce
    Sentandreu-Mano, Trinidad
    Forcano, Silvia
    Cezon-Serrano, Natalia
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (05) : 1 - 14
  • [44] Comparison of EWGSOP-1and EWGSOP-2 diagnostic criteria on prevalence of and risk factors for sarcopenia among Iranian older people: the Bushehr Elderly Health (BEH) program
    Shafiee, Gita
    Heshmat, Ramin
    Ostovar, Afshin
    Khatami, Fatemeh
    Fahimfar, Noushin
    Arzaghi, Seyed Masoud
    Gharibzadeh, Safoora
    Hanaei, Sara
    Nabipour, Iraj
    Larijani, Bagher
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2020, 19 (02) : 727 - 734
  • [45] Prevalence of sarcopenia in older women and level of agreement between the diagnostic instruments proposed by the European Working Group on Sarcopenia in Older People 2 (EWGSOP2)
    Daiana Vieira Sutil
    Adriana Netto Parentoni
    Leonardo Augusto Da Costa Teixeira
    Bruno de Souza Moreira
    Amanda Aparecida Oliveira Leopoldino
    Vanessa Amaral Mendonça
    Ana Cristina Rodrigues Lacerda
    Ana Lúcia Danielewicz
    Núbia Carelli Pereira de Avelar
    BMC Musculoskeletal Disorders, 24
  • [46] Comparison of EWGSOP-1and EWGSOP-2 diagnostic criteria on prevalence of and risk factors for sarcopenia among Iranian older people: the Bushehr Elderly Health (BEH) program
    Gita Shafiee
    Ramin Heshmat
    Afshin Ostovar
    Fatemeh Khatami
    Noushin Fahimfar
    Seyed Masoud Arzaghi
    Safoora Gharibzadeh
    Sara Hanaei
    Iraj Nabipour
    Bagher Larijani
    Journal of Diabetes & Metabolic Disorders, 2020, 19 : 727 - 734
  • [47] Consequences of applying the different criteria of the EWGSOP2 guideline for sarcopenia case-finding in Spanish community-dwelling older adults
    Montemurro, Alessio
    Ruiz-Cardenas, Juan D.
    Martinez-Garcia, Maria del Mar
    Rodriguez-Juan, Juan J.
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2023, 109
  • [48] THE DIFFERENT DIAGNOSIS CRITERIA OF THE EWGSOP2 DEFINITION AND THEIR RELATIONSHIP WITH 5-YEAR ADVERSE CONSEQUENCES
    Beaudart, C.
    Locquet, M.
    Lengele, L.
    Reginster, J. -Y.
    Bruyere, O.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S58 - S58
  • [49] Muscle Strength Definitions Matter: Prevalence of Sarcopenia and Predictive Validity for Adverse Outcomes Using the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) Criteria
    Chew, J.
    Yeo, A.
    Yew, S.
    Lim, J. P.
    Tay, L.
    Ding, Y. Y.
    Lim, W. S.
    JOURNAL OF NUTRITION HEALTH & AGING, 2020, 24 (06): : 614 - 618
  • [50] Sarcopenia Prevalence and Risk Factors among Japanese Community Dwelling Older Adults Living in a Snow-Covered City According to EWGSOP2
    Su, Ya
    Hirayama, Kengo
    Han, Tian-fang
    Izutsu, Miku
    Yuki, Michiko
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (03)
12345